Journal profile

Journal of innate immunity

Publisher: Karger
ISSN1662-811X | 1662-8128 FormatPrint StatusCurrently indexed

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor
3.76
Citation rate 5.07 402 total citations
h5-index 28 h5 depth signal
Cited share 88.1% 74 of 84
Total citations 402 Citation footprint
Metric signal 4.56 External metric anchor
Self-citation 0.7% 3 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

United States 86
Germany 64
China 50
Sweden 45
Netherlands 30

Citing Fields of Research

Immunology 358
Bacteriology 69
Hematology 50
Virology 34
Antibiotic & Antibacterial Agents 26

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 1,022 Articles tracked across the journal lifetime
Indexed publication set 84 74 cited publications
Last 12 months 31 5.2 publications/month
Open access share 100.0% 31 OA publications in the last year
Leading citing country United States 86 citing publications
Leading citing field Immunology 358 citing publications
Latest tracked publication 12 October 2026 10 recent records available

Coverage & Indexing History

MEDLINE
v1n1, 2009-
PubMed
v1n1, 2009-
PMC
Active Coverage

Research Focus & Classification

Indexed Subjects

Immunology

Broad Categories

Allergy and Immunology Immunology Hematology Antibiotic & Antibacterial Agents Virology Bacteriology Entomology

MeSH Descriptors

Immunity, Innate

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

05
Laura A. Novotny, Carla Martinez-Morant, Stephen A. Duncan et al.
Background: Lambda interferons signal through the interferon lambda receptor-1 (IFNLR1) and IL10RB heterodimer to induce interferon stimulated genes (ISGs). We previously showed that proteins derived from distinct IFNLR1 splice isoforms ...
10
Giorgos Marinakis, Eleni Karakike, Panagiotis Koufargyris et al.
Introduction: Biomarkers to predict response of critical COVID-19 to tocilizumab (TCZ) are under investigation. Serum levels of interleukin (IL)-6 and IL-6 soluble receptors were studied in a cohort of patients all receiving treatment wi...

Bibliographical & Catalog Notes

Title from cover.

Print issues ceased with v. 12 (2019).

Some articles in v. 1 published electronically in 2008.

Also issued online.